Citius Pharmaceuticals, Inc. SEC filings CTXR
Citius Pharmaceuticals, Inc. has 638 filings in SEC EDGAR's recent list, going back to Nov 23, 2010. Its latest annual report, Form ARS, was filed on Feb 24, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (other events). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Aug 10, 2026 | — |
| EFFECT | Filing | Jun 2, 2026 | — |
| CORRESP | Letter to the SEC | May 29, 2026 | — |
| EFFECT | Filing | Mar 1, 2024 | — |
| CORRESP | Letter to the SEC | Feb 29, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 29, 2024 | — |
| 425 | Current report | Oct 24, 2023 | — |
| 25-NSE | Delisting notice | Aug 8, 2022 | — |
| EFFECT | Filing | Jul 8, 2021 | — |
| EFFECT | Filing | May 20, 2021 | — |
| CORRESP | Letter to the SEC | May 19, 2021 | — |
| UPLOAD | Letter from the SEC | May 18, 2021 | — |
| EFFECT | Filing | Apr 16, 2021 | — |
| CORRESP | Letter to the SEC | Apr 12, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 9, 2021 | — |
| SEC STAFF LETTER | Filing | Mar 12, 2021 | — |
| SEC STAFF LETTER | Filing | Feb 11, 2021 | — |
| EFFECT | Filing | Feb 5, 2021 | — |
| CORRESP | Letter to the SEC | Feb 3, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 3, 2021 | — |
| D | Filing | Feb 1, 2021 | — |
| EFFECT | Filing | Sep 30, 2020 | — |
| EFFECT | Filing | Sep 25, 2020 | — |
| CORRESP | Letter to the SEC | Sep 18, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 18, 2020 | — |
| EFFECT | Filing | Jun 12, 2020 | — |
| CORRESP | Letter to the SEC | Jun 11, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 11, 2020 | — |
| D | Filing | May 19, 2020 | — |
| EFFECT | Filing | Apr 24, 2020 | — |
| CORRESP | Letter to the SEC | Apr 17, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 16, 2020 | — |
| EFFECT | Filing | Sep 24, 2019 | — |
| CORRESP | Letter to the SEC | Sep 20, 2019 | — |
| CORRESP | Letter to the SEC | Sep 20, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 19, 2019 | — |
| EFFECT | Filing | Apr 26, 2019 | — |
| CORRESP | Letter to the SEC | Apr 24, 2019 | — |
| UPLOAD | Letter from the SEC | Apr 23, 2019 | — |
| D | Filing | Apr 8, 2019 | — |
| CT ORDER | Filing | Mar 20, 2019 | — |
| EFFECT | Filing | Aug 8, 2018 | — |
| CORRESP | Letter to the SEC | Aug 6, 2018 | — |
| CORRESP | Letter to the SEC | Aug 6, 2018 | — |
| UPLOAD | Letter from the SEC | Aug 3, 2018 | — |
| D | Filing | May 22, 2018 | — |
| EFFECT | Filing | Apr 26, 2018 | — |
| CORRESP | Letter to the SEC | Apr 24, 2018 | — |
| UPLOAD | Letter from the SEC | Apr 24, 2018 | — |
| EFFECT | Filing | Feb 1, 2018 | — |
| CORRESP | Letter to the SEC | Jan 31, 2018 | — |
| CORRESP | Letter to the SEC | Jan 30, 2018 | — |
| UPLOAD | Letter from the SEC | Jan 25, 2018 | — |
| EFFECT | Filing | Jan 19, 2018 | — |
| D | Filing | Dec 20, 2017 | — |
| EFFECT | Filing | Dec 15, 2017 | — |
| CORRESP | Letter to the SEC | Dec 15, 2017 | — |
| CORRESP | Letter to the SEC | Dec 13, 2017 | — |
| UPLOAD | Letter from the SEC | Nov 17, 2017 | — |
| EFFECT | Filing | Aug 2, 2017 | — |
| CERTNAS | Auto-generated paper document | Aug 2, 2017 | — |
| CORRESP | Letter to the SEC | Jul 28, 2017 | — |
| CORRESP | Letter to the SEC | Jul 28, 2017 | — |
| 8-A12B | Form 8-a12b | Jul 28, 2017 | — |
| CORRESP | Letter to the SEC | Jul 27, 2017 | — |
| CORRESP | Letter to the SEC | Jul 24, 2017 | — |
| CORRESP | Letter to the SEC | Jul 24, 2017 | — |
| UPLOAD | Letter from the SEC | May 31, 2017 | — |
| EFFECT | Filing | Apr 11, 2017 | — |
| CORRESP | Letter to the SEC | Apr 7, 2017 | — |
| D/A | Filing | Feb 27, 2017 | — |
| UPLOAD | Letter from the SEC | Feb 22, 2017 | — |
| D | Filing | Dec 8, 2016 | — |
| UPLOAD | Letter from the SEC | Aug 11, 2016 | — |
| PRER14A | Prer 14a | Aug 5, 2016 | — |
| UPLOAD | Letter from the SEC | Jul 20, 2016 | — |
| NT 10-Q | Filing | May 17, 2016 | Mar 31, 2016 |
| EFFECT | Filing | Jan 21, 2016 | — |
| CORRESP | Letter to the SEC | Jan 19, 2016 | — |
| CORRESP | Letter to the SEC | Jan 19, 2016 | — |
| UPLOAD | Letter from the SEC | Jan 8, 2016 | — |
| UPLOAD | Letter from the SEC | Nov 10, 2015 | — |
| UPLOAD | Letter from the SEC | Oct 29, 2015 | — |
| 8-A12G | Filing | Oct 22, 2015 | — |
| CORRESP | Letter to the SEC | Oct 16, 2015 | — |
| UPLOAD | Letter from the SEC | Oct 9, 2015 | — |
| NT 10-Q | Filing | Feb 14, 2014 | Dec 31, 2013 |
| NT 10-K | Nt-10k | Dec 31, 2013 | Sep 30, 2013 |
| NT 10-Q | Filing | Aug 15, 2013 | Jun 30, 2013 |
| NT 10-K | Filing | Dec 31, 2012 | Sep 30, 2012 |
| NT 10-Q | Filing | Aug 15, 2012 | Jun 30, 2012 |
| NT 10-K | Filing | Dec 29, 2011 | Sep 30, 2011 |
| D | Filing | Oct 26, 2011 | — |
| EFFECT | Filing | Jul 12, 2011 | — |
| CORRESP | Letter to the SEC | Jul 11, 2011 | — |
| CORRESP | Letter to the SEC | Jun 22, 2011 | — |
| UPLOAD | Letter from the SEC | Jun 15, 2011 | — |
| CORRESP | Letter to the SEC | Jun 2, 2011 | — |
| UPLOAD | Letter from the SEC | May 20, 2011 | — |
| CORRESP | Letter to the SEC | May 9, 2011 | — |
| UPLOAD | Letter from the SEC | May 3, 2011 | — |
| CORRESP | Letter to the SEC | Apr 19, 2011 | — |
| UPLOAD | Letter from the SEC | Mar 30, 2011 | — |
| CORRESP | Letter to the SEC | Mar 16, 2011 | — |
| UPLOAD | Letter from the SEC | Feb 3, 2011 | — |
| CORRESP | Letter to the SEC | Jan 21, 2011 | — |
| UPLOAD | Letter from the SEC | Dec 20, 2010 | — |
Showing 107 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CTXR (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- NV
- Headquarters
- Cranford, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1506251
- Former names
- Trail One, Inc. (until Sep 18, 2014); TrailOne, Inc. (until Jan 21, 2011)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.